{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:58:17Z","timestamp":1784818697161,"version":"3.55.0"},"reference-count":67,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304250"],"award-info":[{"award-number":["82304250"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273734"],"award-info":[{"award-number":["82273734"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["YQ2022H005"],"award-info":[{"award-number":["YQ2022H005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Heilongjiang Province Natural Science Foundation","award":["82304250"],"award-info":[{"award-number":["82304250"]}]},{"name":"Heilongjiang Province Natural Science Foundation","award":["82273734"],"award-info":[{"award-number":["82273734"]}]},{"name":"Heilongjiang Province Natural Science Foundation","award":["YQ2022H005"],"award-info":[{"award-number":["YQ2022H005"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background Psoriasis (PsO): is an immune-mediated inflammatory disease that imposes a significant burden on patients. Many patients experience relapse or inadequate responses, and PsO subtypes also lack effective therapies, highlighting the need for new therapeutic targets. Methods: We performed a proteome-wide Mendelian randomization (MR) to explore potential therapeutic targets for PsO. Protein quantitative trait loci (pQTLs) data were obtained from the Pharma Proteomics Project (54,219 UK Biobank participants, 2923 proteins), and PsO phenotype and subtype data were sourced from FinnGen (10,312 cases; 397,564 controls) for discovery. Replication MR utilized integrated protein data (Iceland and Norfolk) and phenotype data from multiple databases (UK Biobank and GWAS Catalog). Reverse MR and colocalization were used to support causal relationships. Single-cell RNA-seq analysis revealed distinct expression patterns of protein-coding genes across different cell types in PsO biopsy samples and normal skin tissues. Protein-protein interactions (PPI) and molecular docking were used to evaluate druggability. Results: MR analysis identified 13 proteins significantly associated with PsO risk (p &lt; 2.56\u00d710\u22125), including 10 proteins associated with PsO subtypes. Decreased levels of eight proteins (IFNLR1, APOF, TDRKH, DDR1, HLA-E, LTA, MOG, and ICAM3) and increased levels of five proteins (IFNGR2, HCG22, IL12B, BTN3A2, and TRIM40) showed protective effects against PsO progression. Robust colocalization (PPH4 &gt; 0.9) identified IFNLR1, IFNGR2, APOF, and TDRKH as top candidates. Single-cell RNA sequencing analysis revealed that IFNLR1, IFNGR2, LTA, TDRKH, and DDR1 were specifically expressed in T cells of psoriatic biopsy specimens compared to healthy controls. Molecular docking indicated the druggability of IFNLR1 and IFNGR2. Conclusions: We identified several potential therapeutic targets for PsO, with IFNLR1, IFNGR2, APOF, and TDRKH emerging as promising candidates, particularly IFNLR1 and IFNGR2, which are associated with the IFN family. These findings may provide new perspectives on PsO therapy and pathogenesis.<\/jats:p>","DOI":"10.3390\/biomedicines13061380","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T08:51:04Z","timestamp":1749027064000},"page":"1380","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Integrative Analysis of Plasma Proteomics and Transcriptomics Reveals Potential Therapeutic Targets for Psoriasis"],"prefix":"10.3390","volume":"13","author":[{"given":"Hesong","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenguang","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihao","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"He","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenjing","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Li","sequence":"additional","affiliation":[{"name":"Laboratory for the Study of Metastatic Microenvironments, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Fan","sequence":"additional","affiliation":[{"name":"Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuying","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Health Management, Harbin Medical University, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and Clinical Features of Psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2230.2001.00832.x","article-title":"Psoriasis\u2014Epidemiology and Clinical Spectrum","volume":"26","author":"Christophers","year":"2001","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, Regional, and Worldwide Epidemiology of Psoriasis: Systematic Analysis and Modelling Study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/1346-8138.14698","article-title":"Cancer Risk in 892 089 Patients with Psoriasis in Korea: A Nationwide Population-Based Cohort Study","volume":"46","author":"Lee","year":"2019","journal-title":"J. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/jdv.13619","article-title":"Skin Cancer in Patients with Psoriasis","volume":"30","author":"Egeberg","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jaad.2016.05.021","article-title":"Personal History of Psoriasis and Risk of Nonmelanoma Skin Cancer (NMSC) among Women in the United States: A Population-Based Cohort Study","volume":"75","author":"Dai","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jamadermatol.2020.0024","article-title":"Prevalence, Incidence, and Risk of Cancer in Patients with Psoriasis and Psoriatic Arthritis","volume":"156","author":"Vaengebjerg","year":"2020","journal-title":"JAMA Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40257-020-00521-3","article-title":"Treatment Goals in Psoriasis: Which Outcomes Matter Most?","volume":"21","author":"Svoboda","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","article-title":"Signaling Pathways and Targeted Therapies for Psoriasis","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jid.2017.09.044","article-title":"Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)","volume":"138","author":"Iskandar","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1038\/jid.2015.208","article-title":"Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)","volume":"135","author":"Warren","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","article-title":"Phenome-Wide Mendelian Randomization Mapping the Influence of the Plasma Proteome on Complex Diseases","volume":"52","author":"Zheng","year":"2020","journal-title":"Nat. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian Randomization","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/s41576-021-00387-z","article-title":"Advancing the Use of Genome-Wide Association Studies for Drug Repurposing","volume":"22","author":"Reay","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"King, E.A., Davis, J.W., and Degner, J.F. (2019). Are Drug Targets with Genetic Support Twice as Likely to Be Approved? Revised Estimates of the Impact of Genetic Support for Drug Mechanisms on the Probability of Drug Approval. PLoS Genet., 15.","DOI":"10.1101\/513945"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma Proteomic Associations with Genetics and Health in the UK Biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","article-title":"Large-Scale Integration of the Plasma Proteome with Genetics and Disease","volume":"53","author":"Ferkingstad","year":"2021","journal-title":"Nat. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s42255-023-00753-7","article-title":"Proteogenomic Links to Human Metabolic Diseases","volume":"5","author":"Koprulu","year":"2023","journal-title":"Nat. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1038\/s41586-023-05837-8","article-title":"Author Correction: FinnGen Provides Genetic Insights from a Well-Phenotyped Isolated Population","volume":"615","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Karczewski, K.J., Gupta, R., Kanai, M., Lu, W., Tsuo, K., Wang, Y., Walters, R.K., Turley, P., Callier, S., and Baya, N. (2024). Pan-UK Biobank GWAS Improves Discovery, Analysis of Genetic Architecture, and Resolution into Ancestry-Enriched Effects. medRxiv, preprint.","DOI":"10.1101\/2024.03.13.24303864"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"D977","DOI":"10.1093\/nar\/gkac1010","article-title":"The NHGRI-EBI GWAS Catalog: Knowledgebase and Deposition Resource","volume":"51","author":"Sollis","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bpsgos.2021.03.002","article-title":"Investigating Pleiotropy Between Depression and Autoimmune Diseases Using the UK Biobank","volume":"1","author":"Glanville","year":"2021","journal-title":"Biol. Psychiatry Glob. Open Sci."},{"key":"ref_25","first-page":"100069","article-title":"Transethnic Analysis of Psoriasis Susceptibility in South Asians and Europeans Enhances Fine-Mapping in the MHC and Genomewide","volume":"3","author":"Stuart","year":"2022","journal-title":"HGG Adv."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian Randomization: Genetic Anchors for Causal Inference in Epidemiological Studies","volume":"23","author":"Hemani","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0962280210394459","article-title":"Using Multiple Genetic Variants as Instrumental Variables for Modifiable Risk Factors","volume":"21","author":"Palmer","year":"2012","journal-title":"Stat. Methods Med. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/ijc.33292","article-title":"Causal Relationships between Body Mass Index, Smoking and Lung Cancer: Univariable and Multivariable Mendelian Randomization","volume":"148","author":"Zhou","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Giambartolomei, C., Vukcevic, D., Schadt, E.E., Franke, L., Hingorani, A.D., Wallace, C., and Plagnol, V. (2014). Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics. PLoS Genet., 10.","DOI":"10.1371\/journal.pgen.1004383"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s41588-019-0404-0","article-title":"Abundant Associations with Gene Expression Complicate GWAS Follow-Up","volume":"51","author":"Liu","year":"2019","journal-title":"Nat. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrg3461","article-title":"Pleiotropy in Complex Traits: Challenges and Strategies","volume":"14","author":"Solovieff","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kim, J., Lee, J., Li, X., Kunjravia, N., Rambhia, D., Cueto, I., Kim, K., Chaparala, V., Ko, Y., and Garcet, S. (2023). Multi-Omics Segregate Different Transcriptomic Impacts of Anti-IL-17A Blockade on Type 17 T-Cells and Regulatory Immune Cells in Psoriasis Skin. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1250504"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary Learning for Integrative, Multimodal and Scalable Single-Cell Analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING V11: Protein\u2013Protein Association Networks with Increased Coverage, Supporting Functional Discovery in Genome-Wide Experimental Datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: Towards Direct Deposition of Bioassay Data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: A Major Update to the DrugBank Database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41586-019-0917-9","article-title":"Ultra-Large Library Docking for Discovering New Chemotypes","volume":"566","author":"Lyu","year":"2019","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1021\/acschembio.5b00370","article-title":"Virtual Screening for UDP-Galactopyranose Mutase Ligands Identifies a New Class of Antimycobacterial Agents","volume":"10","author":"Kincaid","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"D488","DOI":"10.1093\/nar\/gkac1077","article-title":"RCSB Protein Data Bank (RCSB.Org): Delivery of Experimentally-Determined PDB Structures alongside One Million Computed Structure Models of Proteins from Artificial Intelligence\/Machine Learning","volume":"51","author":"Burley","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 Update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ng.3314","article-title":"The Support of Human Genetic Evidence for Approved Drug Indications","volume":"47","author":"Nelson","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and Distinct Functions of Type I and Type III Interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-Lambdas Mediate Antiviral Protection through a Distinct Class II Cytokine Receptor Complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1182\/blood.2020006375","article-title":"IFN-\u03bb Therapy Prevents Severe Gastrointestinal Graft-versus-Host Disease","volume":"138","author":"Henden","year":"2021","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"102319","DOI":"10.1016\/j.jaut.2019.102319","article-title":"Lambda Interferons in Immunity and Autoimmunity","volume":"104","author":"Vlachiotis","year":"2019","journal-title":"J. Autoimmun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40257-022-00679-y","article-title":"Time to Relapse After Discontinuing Systemic Treatment for Psoriasis: A Systematic Review","volume":"23","author":"Shourick","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.1074\/jbc.R117.777102","article-title":"Contribution of Type III Interferons to Antiviral Immunity: Location, Location, Location","volume":"292","author":"Kotenko","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2015.07.001","article-title":"Interferon-\u03bb: Immune Functions at Barrier Surfaces and Beyond","volume":"43","author":"Lazear","year":"2015","journal-title":"Immunity"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1080\/08820139.2022.2036187","article-title":"Association between Psoriasis Disease and IFN-\u03bb Gene Polymorphisms","volume":"51","author":"Yilmaz","year":"2022","journal-title":"Immunol. Investig."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.4049\/jimmunol.173.6.3991","article-title":"Characterization of a Dipeptide Motif Regulating IFN-Gamma Receptor 2 Plasma Membrane Accumulation and IFN-Gamma Responsiveness","volume":"173","author":"Rosenzweig","year":"2004","journal-title":"J. Immunol."},{"key":"ref_51","first-page":"170276","article-title":"Neuroinflammation in the Aging Down Syndrome Brain; Lessons from Alzheimer\u2019s Disease","volume":"2012","author":"Wilcock","year":"2012","journal-title":"Curr. Gerontol. Geriatr. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4049\/jimmunol.2001310","article-title":"IFN-\u03b3 Drives Human Monocyte Differentiation into Highly Proinflammatory Macrophages That Resemble a Phenotype Relevant to Psoriasis","volume":"207","author":"Angell","year":"2021","journal-title":"J. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e2117523119","DOI":"10.1073\/pnas.2117523119","article-title":"Up-Regulation of BTN3A1 on CD14+ Cells Promotes V\u03b39V\u03b42 T Cell Activation in Psoriasis","volume":"119","author":"Zhou","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"He, J., Zhao, M., Ma, X., Li, D., Kong, J., and Yang, F. (2023). The Role and Application of Three IFN-Related Reactions in Psoriasis. Biomed. Pharmacother., 167.","DOI":"10.1016\/j.biopha.2023.115603"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1016\/j.cell.2021.11.018","article-title":"Stem-like Intestinal Th17 Cells Give Rise to Pathogenic Effector T Cells during Autoimmunity","volume":"184","author":"Schnell","year":"2021","journal-title":"Cell"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Manivasagam, S., and Klein, R.S. (2021). Type III Interferons: Emerging Roles in Autoimmunity. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.764062"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-025-07698-5","article-title":"An Integrated Multi-Omics Analysis Identifies Protein Biomarkers and Potential Drug Targets for Psoriatic Arthritis","volume":"8","author":"Cai","year":"2025","journal-title":"Commun. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/hep.32631","article-title":"Apolipoprotein F Is Reduced in Humans with Steatosis and Controls Plasma Triglyceride-rich Lipoprotein Metabolism","volume":"77","author":"Deprince","year":"2023","journal-title":"Hepatology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13075-023-03122-7","article-title":"Causal Relationship between PCSK9 Inhibitor and Autoimmune Diseases: A Drug Target Mendelian Randomization Study","volume":"25","author":"Xie","year":"2023","journal-title":"Arthritis Res. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00403-024-03191-x","article-title":"Plasma Proteins and Inflammatory Dermatoses: Proteome-Wide Mendelian Randomization and Colocalization Analyses","volume":"316","author":"Liu","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/emboj.2013.121","article-title":"Tdrkh Is Essential for Spermatogenesis and Participates in Primary piRNA Biogenesis in the Germline","volume":"32","author":"Saxe","year":"2013","journal-title":"EMBO J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-021-04057-2","article-title":"Tumour DDR1 Promotes Collagen Fibre Alignment to Instigate Immune Exclusion","volume":"599","author":"Sun","year":"2021","journal-title":"Nature"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1007\/s00415-018-9122-2","article-title":"Neurological Update: MOG Antibody Disease","volume":"266","author":"Jacob","year":"2019","journal-title":"J. Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.4049\/jimmunol.178.4.2589","article-title":"IL-23 Is Critical in the Induction but Not in the Effector Phase of Experimental Autoimmune Encephalomyelitis","volume":"178","author":"Thakker","year":"2007","journal-title":"J. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2018.02.034","article-title":"ICAM3 Mediates Inflammatory Signaling to Promote Cancer Cell Stemness","volume":"422","author":"Shen","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/intbio\/zyaa022","article-title":"Endothelial Cell Apicobasal Polarity Coordinates Distinct Responses to Luminally versus Abluminally Delivered TNF-\u03b1 in a Microvascular Mimetic","volume":"12","author":"Salminen","year":"2020","journal-title":"Integr. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41467-023-36424-0","article-title":"TRIM40 Is a Pathogenic Driver of Inflammatory Bowel Disease Subverting Intestinal Barrier Integrity","volume":"14","author":"Kang","year":"2023","journal-title":"Nat. Commun."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/6\/1380\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:46:34Z","timestamp":1760031994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/6\/1380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":67,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["biomedicines13061380"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13061380","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]}}}